KalVista Pharmaceuticals (KALV) Revenue Growth (1y) (2015 - 2020)
KalVista Pharmaceuticals (KALV) Revenue Growth (1y) (2015 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 64.03% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2020 | 30.69% |
| Jan 31, 2020 | -59.46% |
| Oct 31, 2019 | -29.90% |
| Jul 31, 2019 | -9.39% |
| Apr 30, 2019 | -39.55% |
| Jan 31, 2019 | 66.88% |
| Oct 31, 2018 | 396.18% |
| Jul 31, 2018 | 3,772.92% |
| Apr 30, 2018 | 4,145.61% |
| Jan 31, 2018 | 839.92% |
| Oct 31, 2017 | 472.08% |
| Jul 31, 2017 | -90.15% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | -12.50% |
| Sep 30, 2015 | -30.00% |
| Jun 30, 2015 | 40.00% |
| Mar 31, 2015 | 16.67% |